XML 44 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Millions
 2 Months Ended
Jul. 21, 2021
Jul. 21, 2021
Jun. 30, 2021
Apr. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Subsequent events            
Borrowings     $ 27,495   $ 20,380  
Undrawn committed bank facilities $ 9,500 $ 9,500 4,100      
Borrowings cancelled 4,500          
Intangible assets     20,006   20,947 $ 19,728
Alexion Pharmaceuticals, Inc.            
Subsequent events            
Consideration paid (received) 13,300          
Borrowings $ 4,000 $ 4,000 $ 8,000      
Undrawn committed bank facilities         $ 9,500  
Acerta Pharma Acquisition            
Subsequent events            
Ownership interest acquired (as a percent)       45.00%    
Major business combination | Alexion Pharmaceuticals, Inc.            
Subsequent events            
Ownership interest acquired (as a percent) 100.00% 100.00%        
Consideration paid (received) $ 40,000          
Cash Alexion shareholders will receive for each of their Alexion shares $ 60 $ 60        
Total amount of cash paid in consideration $ 13,000          
Major business combination | Alexion Pharmaceuticals, Inc. | American Depository Shares            
Subsequent events            
Number of shares Alexion shareholders will receive for each of their Alexion shares 2.1243 2.1243        
Total fair value of shares Alexion shareholders will receive $ 27,000 $ 27,000        
New Borrowing            
Subsequent events            
Borrowings 17,500 17,500        
Undrawn committed bank facilities $ 1,000 1,000        
Borrowings cancelled   $ 12,500